GLP-1s may not increase likelihood for basal insulin discontinuation in type 2 diabetes

Adults with type 2 diabetes have a similar likelihood for insulin discontinuation if they were using a concomitant GLP-1 receptor agonist compared with an SGLT2 or DPP-IV inhibitor, researchers reported in Annals of Internal Medicine. In a target trial emulation using electronic health record data from the Veterans Health Administration Corporate Data Warehouse, researchers found that 16% to 18%